Intersect ENT raises $55M after pricing IPO low, stock pops in debut

Nasal implant maker Intersect ENT raised $55 million in an IPO that priced at the low end of its target range and then saw its shares hit the top of that range in early trading on Thursday...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.